Hunan Central Xiangzhong Pharmaceutical

Hunan Central Xiangzhong Pharmaceutical Co., Ltd., a subsidiary of China National Nuclear Corporation (CNNC), is a comprehensive pharmaceutical enterprise located in Shaoyang, Hunan Province. The company specializes in the research, development, and large-scale manufacturing of chemical raw materials (APIs) and finished dosage forms, including tablets, capsules, and injections. It is particularly recognized for its production of psychotropic and neurological medications, such as sodium valproate and carbamazepine, holding a significant market share in China. The company operates under strict GMP standards and exports its products to various international markets, positioning itself as a key player in the domestic chemical-pharmaceutical industry.